Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
37.53
+1.60 (4.45%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Sionna Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -75.27 | -61.69 | -47.26 | -40.24 |
| Depreciation & Amortization | 0.65 | 0.67 | 0.58 | 0.12 |
| Loss (Gain) From Sale of Investments | -3.05 | -3 | -0.68 | -0.4 |
| Stock-Based Compensation | 12.07 | 3.71 | 2.26 | 1.69 |
| Other Operating Activities | 1.96 | 10.6 | 2.18 | - |
| Change in Accounts Payable | -0.42 | 0.47 | 0.16 | -1.51 |
| Change in Other Net Operating Assets | -2.24 | -3.54 | -0.95 | 4.28 |
| Operating Cash Flow | -66.3 | -52.79 | -43.7 | -36.07 |
| Capital Expenditures | -0.38 | -0.03 | -1.12 | -1.87 |
| Investment in Securities | -118.37 | -126.89 | 28.47 | -27.39 |
| Investing Cash Flow | -118.75 | -126.91 | 27.35 | -29.26 |
| Issuance of Common Stock | 205.71 | 0.14 | 0.03 | 0.06 |
| Other Financing Activities | - | -2.5 | - | -0.2 |
| Financing Cash Flow | 205.71 | 178.97 | 0.03 | 110.86 |
| Net Cash Flow | 20.66 | -0.73 | -16.32 | 45.52 |
| Free Cash Flow | -66.67 | -52.81 | -44.82 | -37.94 |
| Free Cash Flow Per Share | -1.67 | -13.69 | -15.28 | -14.72 |
| Levered Free Cash Flow | -44.26 | -40.48 | -30.14 | - |
| Unlevered Free Cash Flow | -44.26 | -40.48 | -30.14 | - |
| Change in Working Capital | -2.65 | -3.08 | -0.78 | 2.76 |
Source: S&P Capital IQ. Standard template.
Financial Sources.